To explore CD47’s effect on ovarian cancer TME, Yu and Ding et al. employed two different data sets from the Tumor Immune Single-cell Hub (TISCH) single cell database to detect the immune cells' distribution at the site of primary quantitative metastatic ovarian tumors. This evidence concerns the gene CD47 and ovarian carcinoma.